Koers BioForce Nanosciences Holdings, Inc. Other OTC
Aandelen
BFNH
US09064C2061
Overige speciaalzaken
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 58,84 mln. 54,18 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | - |
Nettoschuld 2022 | 173K 160K | Nettoschuld 2023 | 220K 203K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-120
x | K/w-verhouding 2023 |
-101
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 14,4% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gagnon
CEO | Chief Executive Officer | 62 | 30-11-21 |
John LaViolette
CEO | Chief Executive Officer | 62 | 30-11-21 |
Sasha Shapiro
PSD | President | 61 | 30-11-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Merle Ferguson
CHM | Chairman | 76 | 08-07-13 |
Richard Kaiser
DFI | Director of Finance/CFO | 59 | 01-07-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 843 mln. | |
+10,24% | 684 mln. | |
+30,88% | 486 mln. | |
+38,09% | 262 mln. | |
0,00% | 135 mln. | |
+126,09% | 64,29 mln. |